Muna Therapeutics
PrivateLast Round
Grant
Jan 8, 2026
Total Funding Raised
$113.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Muna Therapeutics operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Grant round in January 2026.
Muna Therapeutics is a biopharmaceutical company that discovers and develops small-molecule therapeutics aimed at slowing or halting the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Muna Therapeutics Comparables
Compare Muna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AstronauTx | 86% | |
| Vanqua Bio | 81% | |
| Cajal Neuroscience | 81% |
For institutional investors. Book with your work email.
Muna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 8, 2026 | ||||
| Strategic | Dec 5, 2024 | ||||
| Series B | Oct 17, 2023 | ||||
| Grant | Oct 11, 2022 | ||||
| Series A | Jul 9, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Muna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series A |
| LF Investments | Series A |
| AXXAM Family Office | Series A |
| Droia Ventures | Seed, Series A |
| V-Bio Ventures | Series A |
| Novo Holdings | Seed, Series A |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 123% MoM.
- Apr 16, 2026
Monthly visitors grew 266% MoM, reaching 18.9K.
For institutional investors. Book with your work email.
Muna Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Muna Therapeutics's valuation, stock price, and market status.
Is Muna Therapeutics a public or private company?
Muna Therapeutics is a private company.
What is the current stock price of Muna Therapeutics?
Muna Therapeutics is a private company, so its shares have no public market price. Caplight tracks Muna Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Muna Therapeutics worth (valuation)?
Valuation information for Muna Therapeutics is not publicly available.
Can I buy Muna Therapeutics stock?
Muna Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Muna Therapeutics's last funding round?
Muna Therapeutics's most recent funding round was Grant on January 8, 2026.
Who are the main investors in Muna Therapeutics?
Key investors in Muna Therapeutics include Droia Ventures, Novo Holdings, Sofinnova Partners, LSP Dementia Fund.
Will Muna Therapeutics IPO soon?
No public IPO plans have been announced for Muna Therapeutics.
How can I track Muna Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Muna Therapeutics's shares on secondary markets.